| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 52.38 | -0.07 (-0.13%) | 38.64 - 57.00 | 30.5 thousand (Above Avg) |
Market data as of 4:00PM 05/24/13. Quotes are delayed by at least 15 min.
| Open | 52.94 |
|---|---|
| Previous Close | 52.45 |
| Day's Range | 51.20 - 52.94 |
| Market Cap | 177.0M |
| Avg Volume (10 Day) | 27.4K |
| Price/Earnings (Trailing 12 Mo.) | 22.8x |
| Earnings Per Share (Trailing 12 Mo.) | 2.3 |
| Dividend Yield | 0.14 (1.07%) |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Pass |
|---|---|
| Room to increase dividends? | Pass |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
No news headlines available for MLAB
| MLAB | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 22.46% | |
| Net Income Growth (1yr) | 2.44% | |
| Total Debt/Equity | 0.10 | |
| LT Debt/Equity | 0.10 | |
| Earnings Yield | 4.39% | |
| Price/Sales | 3.86 |
| Company | Last | Change |
|---|---|---|
| Utah Medical Products Inc | 47.98 | -0.12% |
| Rochester Medical Corp | 14.66 | 0.00% |
| Alphatec Holdings Inc | 1.95 | +0.52% |
| AtriCure Inc | 9.28 | -0.22% |
| Harvard Bioscience Inc | 5.13 | -0.58% |
Data is delayed by at least 15 min.